Barentz acquires Anshul Life Sciences to strengthen India portfolio
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Highly effective preservation solutions ensuring the safety and protection of personal care products
Subscribe To Our Newsletter & Stay Updated